ID   PER-255
AC   CVCL_W980
SY   PER 255
DR   Wikidata; Q54947178
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2546623;
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 84-95 hours (PubMed=2546623); 66 hours (PubMed=17117183).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 19
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 23,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=2546623; DOI=10.1182/blood.V74.1.369.369;
RA   Kees U.R., Lukeis R., Ford J., Garson O.M.;
RT   "Establishment and characterization of a childhood T-cell acute
RT   lymphoblastic leukemia cell line, PER-255, with chromosome
RT   abnormalities involving 7q32-34 in association with T-cell
RT   receptor-beta gene rearrangement.";
RL   Blood 74:369-373(1989).
//
RX   PubMed=7541097;
RA   Kees U.R., Ashman L.K.;
RT   "Synergistic action of interleukin-2 and Steel factor (SLF) on a human
RT   T lymphoblastoid cell line.";
RL   Leukemia 9:1046-1050(1995).
//
RX   PubMed=12883040;
RA   Kees U.R., Ford J., Watson M., Murch A.R., Ringner M., Walker R.L.,
RA   Meltzer P.S.;
RT   "Gene expression profiles in a panel of childhood leukemia cell lines
RT   mirror critical features of the disease.";
RL   Mol. Cancer Ther. 2:671-677(2003).
//
RX   PubMed=17117183; DOI=10.1038/sj.bjc.6603447;
RA   Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J.,
RA   Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.;
RT   "Authenticity and drug resistance in a panel of acute lymphoblastic
RT   leukaemia cell lines.";
RL   Br. J. Cancer 95:1537-1544(2006).
//